United States Proton Therapy Market Forecasts 2025-2033, with Insights on Number of Patients Treated at US Proton Therapy Centers
16 janv. 2025 06h04 HE
|
Research and Markets
Dublin, Jan. 16, 2025 (GLOBE NEWSWIRE) -- The "United States Proton Therapy Market Size, Growth and Forecast 2025-2033" report has been added to ResearchAndMarkets.com's offering.The United States...
Radiotherapy/Radiation Oncology Devices Market Insights, Competitive Landscape and Market Forecast to 2030
07 janv. 2025 08h33 HE
|
Research and Markets
Dublin, Jan. 07, 2025 (GLOBE NEWSWIRE) -- The "Radiotherapy/Radiation Oncology Devices - Market Insights, Competitive Landscape, and Market Forecast -2030" report has been added to ...
ITM to Present at the 43rd Annual J.P. Morgan Healthcare Conference
13 déc. 2024 05h00 HE
|
ITM Isotope Technologies Munich SE
Garching / Munich, Germany, December 13, 2024 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced that its Chief Executive Officer, Dr. Andrew...
Saudi Arabia Radiotherapy Markets, Competition, Forecast & Opportunities, 2029, Profiles of Key Players - Gulf Medical, Siemens Industrial, Almana Group of Hospitals, and Varian Medical
21 nov. 2024 10h57 HE
|
Research and Markets
Dublin, Nov. 21, 2024 (GLOBE NEWSWIRE) -- The "Saudi Arabia Radiotherapy Market, By Region, Competition, Forecast & Opportunities, 2019-2029F" report has been added to ResearchAndMarkets.com's...
Metastatic Colorectal Cancer Market Forecast to Reach US$ 9,787.5 Million by 2034, Growing at 5.1% CAGR | Fact.MR Report
20 nov. 2024 07h30 HE
|
FACT.MR
Rockville, MD, Nov. 20, 2024 (GLOBE NEWSWIRE) -- According to Fact.MR, a market research and competitive intelligence provider, the global metastatic colorectal cancer market is estimated to reach a...
Radiation Oncology Market Size to Hit USD 28.07 Billion by 2033 | Straits Research
11 nov. 2024 10h20 HE
|
Straits Research Private Limited - Garner Insights
New York, United States , Nov. 11, 2024 (GLOBE NEWSWIRE) -- Radiation oncology (radiotherapy/radiotherapy) is a medical specialty that must be incorporated into interdisciplinary cancer treatment...
ITM to Participate in Upcoming Investor Conferences
11 nov. 2024 05h00 HE
|
ITM Isotope Technologies Munich SE
Garching / Munich, November 11, 2024 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced its participation in two upcoming industry investor...
ITM, TUM und das TUM Universitätsklinikum unterzeichnen eine neue Rahmenvereinbarung zur Entwicklung innovativer radiopharmazeutischer Krebstherapien
24 oct. 2024 05h00 HE
|
ITM Isotope Technologies Munich SE
Neufahrn / Garching / München, 24. Oktober 2024 – ITM Isotope Technologies Munich SE (ITM), ein führendes radiopharmazeutisches Unternehmen, die Technische Universität München (TUM) und das TUM...
ITM, TUM, and TUM University Hospital Sign New Framework Agreement to Advance Innovative Radiopharmaceutical Cancer Treatments
24 oct. 2024 05h00 HE
|
ITM Isotope Technologies Munich SE
Neufahrn / Garching / Munich, Germany, October 24, 2024 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, the Technical University of Munich (TUM) and the TUM...
ITM and NTP Strengthen Global Radioisotope Production Capacities by Renewing their Technology License Agreement and Signing a Manufacturing and Supply Agreement for n.c.a. Lutetium-177
18 oct. 2024 05h00 HE
|
ITM Isotope Technologies Munich SE
Extension of 2012 agreement grants NTP the rights to manufacture and distribute non-carrier-added Lutetium-177 (n.c.a. 177Lu)Companies enter into an additional manufacturing and supply...